Product
Follitropin delta
Aliases
FE 999049, REKOVELLE
6 clinical trials
7 indications
Indication
Controlled Ovarian StimulationIndication
In vitro fertilization (IVF)Indication
infertilityIndication
Oocyte DonationIndication
Oocyte donationIndication
InfertilityIndication
FertilityClinical trial
Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic GonadotropinStatus: Active (not recruiting), Estimated PCD: 2023-09-30
Clinical trial
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre, Pan-Asian Trial Comparing the Efficacy and Safety of FE 999049 With Follitropin Alfa (GONAL-F) in Controlled Ovarian Stimulation in Women Undergoing Assisted Reproductive Technology ProgrammeStatus: Completed, Estimated PCD: 2020-01-03
Clinical trial
A Randomised, Controlled, Assessor-blind, Parallel Groups, Multicentre Trial Assessing the Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese Women Undergoing an Assisted Reproductive Technology ProgrammeStatus: Completed, Estimated PCD: 2019-06-10
Clinical trial
Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone: a Randomized Cross Over Pilot TrialStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
The Performance of an Individual Dosing Regimen of Follitropin Delta for Controlled Ovarian Stimulation for IVF in a Real-word Setting: a Non-interventional Observational StudyStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
A Randomised, Partially Double-blind, Placebo-controlled, Parallel-group Exploratory Trial to Investigate the Effect of FE999302 in Women Undergoing Controlled Ovarian Stimulation With a Fixed Dose of Follitropin Delta in a Gonadotropin-releasing Hormone Antagonist ProtocolStatus: Not yet recruiting, Estimated PCD: 2026-11-11